Protective efficacy of heat-inactivated B. thailandensis, B. mallei or B. pseudomallei against experimental melioidosis and glanders (Q57942331)

2

0 references

S.V. Harding

3

0 references

Timothy. P. Atkins

4

0 references

Richard. W. Titball

Melioidosis survey in Kenya

5

0 references

language of work or name

English

0 references

publication date

July 2009

0 references

published in

Vaccine

0 references

volume

27

0 references

issue

33

0 references

page(s)

4447-4451

0 references

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.040

Burkholderia pseudomallei and melioidosis: be aware in temperate area

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.040

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.040

Pathogenesis of and immunity to melioidosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.040

The Pseudomallei Group: A Review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.040

Melioidosis: the tip of the iceberg?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.040

Septicaemic melioidosis: a review of 50 cases from Malaysia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.040

Use of 16S rRNA gene sequencing for rapid identification and differentiation of Burkholderia pseudomallei and B. mallei.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.040

Glanders in a military research microbiologist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.040

Multilocus Sequence Typing and Evolutionary Relationships among the Causative Agents of Melioidosis and Glanders, Burkholderia pseudomallei and Burkholderia mallei

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.040

Antilipopolysaccharide II: an antibody protective against fatal melioidosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.040

Passive protection against Burkholderia pseudomallei infection in mice by monoclonal antibodies against capsular polysaccharide, lipopolysaccharide or proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.040

Evaluation of lipopolysaccharide and capsular polysaccharide as subunit vaccines against experimental melioidosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.040

Monoclonal antibodies passively protect BALB/c mice against Burkholderia mallei aerosol challenge

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.040

Passive protection of diabetic rats with antisera specific for the polysaccharide portion of the lipopolysaccharide isolated from Pseudomonas pseudomallei

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.040

Isolation and Characterization of Gal E Mutant Ty 21a of Salmonella typhi: A Candidate Strain for a Live, Oral Typhoid Vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.040

Nonviable Burkholderia mallei induces a mixed Th1- and Th2-like cytokine response in BALB/c mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.040

A model of immunity to Burkholderia pseudomallei: unique responses following immunization and acute lethal infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.040

Protection against heterologous Burkholderia pseudomallei strains by dendritic cell immunization.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.040

Efficacy of doxycycline and ciprofloxacin against experimental Yersinia pestis infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.040

Lipopolysaccharide heterogeneity among Burkholderia pseudomallei from different geographic and clinical origins.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.040

Biodefense-driven murine model of pneumonic melioidosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.040

Development of protective immunity in a murine model of melioidosis is influenced by the source of Burkholderia pseudomallei antigens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.040

Characterisation of an acapsular mutant of Burkholderia pseudomallei identified by signature tagged mutagenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.040

Detection of bacterial virulence genes by subtractive hybridization: identification of capsular polysaccharide of Burkholderia pseudomallei as a major virulence determinant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.040

Humoral and cell-mediated adaptive immune responses are required for protection against Burkholderia pseudomallei challenge and bacterial clearance postinfection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.040

Role of T cells in innate and adaptive immunity against murine Burkholderia pseudomallei infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.040

A live experimental vaccine against Burkholderia pseudomallei elicits CD4+ T cell-mediated immunity, priming T cells specific for 2 type III secretion system proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.040

Exposure to Burkholderia pseudomallei induces cell-mediated immunity in healthy individuals.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.040

The identification of surface proteins of Burkholderia pseudomallei

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.040

Studies on certain biological characteristics of Malleomyces mallei and Malleomyces pseudomallei; morphology, cultivation, viability, and isolation from contaminated specimens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.040

inferred from DOI database lookup

7 January 2021

based on heuristic

Specificity and functional activity of anti-Burkholderia pseudomallei polysaccharide antibodies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.040